跳至主要内容
临床试验/KCT0009488
KCT0009488招募中Unknown

Clinical efficacy of pre-operative [F-18] Florastamin PSMA PET/CT in men with intermediate- or high-risk localized prostate cancer who undergo radical prostatectomy: Prospective single-arm clinical trial

Seoul National University Hospital0 个研究点目标入组 152 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
152

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19(Year) 至 80(Year)(—)
性别
Male

入选标准

  • Male patients aged 19 to 80 years
  • Patients diagnosed with histopathologically confirmed prostate cancer
  • Intermediate or high-risk prostate cancer according to the D'Amico classification
  • Adequate functional status to carry out normal daily activities (Eastern Cooperative Oncology Group performance status of 0 or 1)
  • Patients capable of understanding and voluntarily consenting to the contents of the informed consent form

排除标准

  • Patients suspected of pelvic distant metastases based on imaging or tissue examination
  • Patients with prior pelvic radiotherapy
  • Patients who have received hormone therapy, neoadjuvant chemotherapy, or radiotherapy for prostate cancer
  • Patients with reported allergies to substances used in previous PET/CT or MRI scans or research
  • Life expectancy of less than 5 years
  • Uncontrolled infectious diseases (persistent sepsis with fever despite treatment)
  • Mental disorders (schizophrenia, bipolar disorder, intellectual disability)
  • Patients with moderate to severe cardiovascular, cerebrovascular, respiratory, or hepatic diseases or other comorbidities that render them unsuitable for clinical trial participation
  • Patients diagnosed with another type of cancer within 2 years (excluding non-metastatic skin basal cell or cutaneous superficial squamous cell carcinoma (T1-3N0M0) or superficial bladder cancer)
  • Patients with pelvic metal implants affecting the quality of PET/CT images
  • Other patients deemed unsuitable for participation in the clinical trial according to investigator discretion
  • Claustrophobia
  • Patients who have undergone Ga-68 PSMA-11 PET-CT before treatment

研究者

相似试验